130 related articles for article (PubMed ID: 9168075)
21. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
22. [Level of total cholesterol in serum of patients with breast cancer treated with tamoxifen].
Wojtacki J; Dziewulska-Bokiniec A
Pol Tyg Lek; 1993 Jun 7-14; 48(23-24):505-6. PubMed ID: 8170824
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of hormone-sensitive breast cancer progression on antiestrogen therapy. Implications for treatment and protocol planning.
Pommier RF; Woltering EA; Keenan EJ; Fletcher WS
Arch Surg; 1987 Nov; 122(11):1311-6. PubMed ID: 2960297
[TBL] [Abstract][Full Text] [Related]
24. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
[TBL] [Abstract][Full Text] [Related]
25. [Plasma estrogen level in patients with cervical cancer].
Zheng Y
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):404-5. PubMed ID: 2076633
[TBL] [Abstract][Full Text] [Related]
26. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
27. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.
Bellet M; Gray KP; Francis PA; Láng I; Ciruelos E; Lluch A; Climent MA; Catalán G; Avella A; Bohn U; González-Martin A; Ferrer R; Catalán R; Azaro A; Rajasekaran A; Morales J; Vázquez J; Fleming GF; Price KN; Regan MM
J Clin Oncol; 2016 May; 34(14):1584-93. PubMed ID: 26729437
[TBL] [Abstract][Full Text] [Related]
28. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
29. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
[TBL] [Abstract][Full Text] [Related]
30. Ovarian cysts in women receiving tamoxifen for breast cancer.
Mourits MJ; de Vries EG; Willemse PH; ten Hoor KA; Hollema H; Sluiter WJ; de Bruijn HW; van der Zee AG
Br J Cancer; 1999 Apr; 79(11-12):1761-4. PubMed ID: 10206289
[TBL] [Abstract][Full Text] [Related]
31. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.
Ernster VL; Wrensch MR; Petrakis NL; King EB; Miike R; Murai J; Goodson WH; Siiteri PK
J Natl Cancer Inst; 1987 Nov; 79(5):949-60. PubMed ID: 3479643
[TBL] [Abstract][Full Text] [Related]
32. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
33. Adrenal function under long-term raloxifene administration.
Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
[TBL] [Abstract][Full Text] [Related]
34. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
[TBL] [Abstract][Full Text] [Related]
35. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
36. Relationship of obesity to blood estrogens.
Zumoff B
Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
[TBL] [Abstract][Full Text] [Related]
37. Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Carlström K; Pousette A; Rannevik G; Sköldefors H; Theve NO; Wilking N
Breast Cancer Res Treat; 1986; 7 Suppl():S107-9. PubMed ID: 2943337
[No Abstract] [Full Text] [Related]
38. Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
Jansson A; Delander L; Gunnarsson C; Fornander T; Skoog L; Nordenskjöld B; Stål O
Clin Cancer Res; 2009 May; 15(10):3610-6. PubMed ID: 19401349
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.
Ingle JN; Suman VJ; Johnson PA; Krook JE; Mailliard JA; Wheeler RH; Loprinzi CL; Perez EA; Jordan VC; Dowsett M
Clin Cancer Res; 1999 Jul; 5(7):1642-9. PubMed ID: 10430063
[TBL] [Abstract][Full Text] [Related]
40. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]